Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02606773Phase 1Completed
Phase 1, randomised, open-label trial (4 arms), sponsored by Semmelweis University. Primary endpoint: Plasma ascorbic acid concentration area under curve at 360 minutes. Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02606773.